China SXT Pharmaceuticals (China SXT Pharmaceuticals) Accounts Payable & Accrued Expense : $5.05 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Accounts Payable & Accrued Expense?

China SXT Pharmaceuticals's quarterly accounts payable & accrued expense increased from Sep. 2022 ($4.88 Mil) to Mar. 2023 ($10.83 Mil) but then declined from Mar. 2023 ($10.83 Mil) to Sep. 2023 ($5.05 Mil).

China SXT Pharmaceuticals's annual accounts payable & accrued expense declined from Mar. 2021 ($16.99 Mil) to Mar. 2022 ($14.88 Mil) and declined from Mar. 2022 ($14.88 Mil) to Mar. 2023 ($10.83 Mil).

China SXT Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for China SXT Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Accounts Payable & Accrued Expense Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5.76

4.88

16.99

14.88

10.83

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial									7.25	14.88	4.88	10.83	5.05

China SXT Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.